Genomic and epigenomic alterations in prostate cancer

Genomic and epigenomic alterations in prostate cancer

Prostate cancer (PC) is the second most frequently diagnosed cancer and the second leading cause of cancer deaths in man. The treatment of localized PC includes surgery or radiation therapy. In case of relapse after a definitive treatment or in patients with locally advanced or metastatic disease, t...

Full description

Bibliographic Details
Main Authors: Anna Maria eAschelter, Silvana eGiacinti, Paola eCaporello, Paolo eMarchetti
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-11-01
Series:Frontiers in Endocrinology
Subjects:
chemotherapy
prostate cancer
Resistance
Epigenomic
hormone therapy
HRPC
Online Access:http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00128/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00128/full

Similar Items